Earnings ·
Canton Strategic Holdings, Inc. reported financial results for the second quarter ended June 30, 2026, recording its…
CNTNCanton Strategic Holdings, Inc.
Canton Strategic Holdings, Inc. reported financial results for the second quarter ended June 30, 2026, recording its first operating revenue of $1,495,859 from Super Validator operations and a new locking-as-a-service (LaaS) offering that generated approximately $1.3 million. The company completed the sale of its legacy biotechnology subsidiary Gravitas Life Sciences for an unsecured promissory note with a principal amount of $3,500,000 bearing 15% payment-in-kind interest. Net loss from continuing operations was $19,254,826, or $(0.08) per share, driven by a $23.7 million unrealized loss on digital asset holdings and stock-based compensation expenses. Cash and cash equivalents increased to $37.2 million, while total assets reached $564.6 million. The company operates in the blockchain infrastructure and financial technology sector.